Page 227 - วารสารการแพทย์แผนไทยและการแพทย์ ทางเลือก ปีที่ 19 ฉบับที่ 2 พฤษภาคม-สิงหาคม 2564
P. 227

J Thai Trad Alt Med                                   Vol. 19  No. 2  May-Aug  2021  457




                skin. Hautarzt. 1986;37(3):126-9. (in German)  33.  Luplertlop N, Suwanmanee S. Dermatophytosis: from
            26.  Payakprom P. Quality control of herbal products. GPO   bench to bedside. J Trop Med Parasitol. 2013;36:75-87.
                R&D Newsletter. 2015;22(4):2-7. (in Thai)  34.  Hayette MP, Sacheli R. Dermatophytosis, trends in epi-
            27.  Nakusha D, Prakash K, Vishal P. Emerging trends in topi-  demiology and diagnostic approach. Curr Fungal Infect
                cal antifungal therapy: A review. Inventi Rapid: NDDS.   Rep. 2015;9:164–79.
                2015;2015(2):1-5.                       35.  Ungpakorn R. Mycoses in Thailand: current concerns.
            28.  Schmid-Wendtner M-H, Korting HC. The pH of the skin   Jpn. J. Med. Mycol. 2005;46(2):81-6.
                surface and its impact on the barrier function. Skin   36.  Halla N, Fernandes IP, Heleno SA, Costa P, Boucherit-
                Pharmacol Phsiol. 2006;19(2):296-302.      Otmani Z, Boucherit K, Rodrigues AE, Ferreira ICFR,
            29.  Fiume MM, Heldreth BA, Bergfeld WF, Belsito DV, Hill   Barreiro MF. Cosmetics preservation: a review on present
                RA, Klaassen CD, Liebler DC, Marks Jr JG, Shank RC,   strategies. Molecules. 2018;23(7):1571.
                Slaga TJ, Snyder PW, Andersen FA. Safety assessment   37.  Saunte DM, Hasselby JP, Brillowska-Dabrowska A,
                of citric acid, inorganic citrate salts, and alkyl citrate   Frimodt-Møller N, Svejgaard EL. Linnemann D, Nielsen
                esters as used in cosmetics. Int J Toxicol. 2014;33(2   SS, Haedersdal M, Arendrup MC. Experimental guinea
                suppl):16s-46s.                            pig model of dermatophytosis: a simple and useful tool
            30.  Lachenmeier DW. Safety evaluation of topical applica-  for the evaluation of new diagnostics and antifungals.
                tions of ethanol on the skin and inside the oral cavity. J   Med Mycol. 2008;46(4):303-13.
                Occup Med Toxicol. 2008;3:26.           38.  Shimamura T, Kubota N, Shibuya K. Animal model of
            31.  Alió AB, Mendoza M, Zambrano EA, Díaz E, Cavallera   dermatophytosis. J Biomed Biotechnol. 2012;2012:125384.
                E. Dermatophytes growth curve and in vitro suscepti-  39.  Poojary SA. Topical antifungals: A review and their role in
                bility test: a broth micro-titration method. Med Mycol.   current management of dermatophytoses. Clin Dermatol
                2005;43(4):319-25.                         Rev. 2017;1(3):24-9.
            32.  Achterman RR, Smith AR. Oliver BG. White TC. Se-  40.  Garg A, Sharma GS, Goyal AK, Ghosh G, Si SC, Rath G.
                quenced dermatophyte strains: growth rate, conidiation,   Recent advances in topical carriers og anti-fungal agents.
                drug susceptibilities, and virulence in an invertebrate   Heliyon. 2020;6(8):e04663.
                model. Fungal Genet Biol. 2011;48(3):335-41
   222   223   224   225   226   227   228   229   230   231   232